Filing Flows › Ingevity (NGVT) › R&D spending
Ingevity (NGVT) R&D spending by quarter
Ingevity's R&D spending was $8.3M in Q3 2026 (third quarter 2026), +36% from Q2 2026. Over the last 7 quarters it ranged from $6.1M (Q2 2026) to $8.3M (Q3 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $8.3M | +36% | +19% |
| Q2 2026 | $6.1M | -9% | -22% |
| Q1 2026 | $6.7M | -9% | -13% |
| Q4 2025 | $7.4M | +6% | — |
| Q3 2025 | $7.0M | -10% | — |
| Q2 2025 | $7.8M | +1% | — |
| Q1 2025 | $7.7M | — | — |
Q3 2026 at a glance
Ingevity, Q3 2026: revenue $305M (-8% year over year), operating margin 22.0%, net earnings $49.3M, operating cash flow $99.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is Ingevity's R&D spending?
Ingevity's R&D spending was $8.3M in Q3 2026 (third quarter 2026), +36% from Q2 2026.
How has Ingevity's R&D spending changed?
Over the last 7 quarters it ranged from $6.1M (Q2 2026) to $8.3M (Q3 2026).